The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease.
Tingfeng WuJunzhao YeCongxiang ShaoYansong LinWei WangShiting FengBihui ZhongPublished in: Clinical and translational gastroenterology (2022)
Advanced liver fibrosis significantly reduces the predictive value of Lp(a) levels for the risk of carotid atherosclerosis in patients with MAFLD.